Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949
Clinical trial NCT02099071 · COMPLETED
Trial details
- NCT number
- NCT02099071
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2012-05-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.